Twist Bioscience Corporation (TWST) income statement
NASDAQ · Healthcare · Biotechnology · 979 employees · CEO Emily Marine Leproust
- Price
- $152.78 -11.92%
- Market cap
- $10.1B
- Enterprise value
- $10B
- Last report
- Q3 '26 filed 2026-08-03
- Next report
- 2026-11-12 EPS est. -$0.38
Twist Bioscience Corporation (TWST) reported revenue of $118M for Q3 '26 (+23.2% year on year), operating income of -$36.3M (-30.6% of revenue) and net income of -$35.1M. Over the last four quarters revenue was $432M.
Income statement
| Income statement | Trend | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $66.9M | $71.5M | $75.3M | $81.5M | $84.7M | $88.7M | $92.8M | $96.1M | $99M | $104M | $111M | $118M | |
| Cost of revenue | $42.4M | $42.5M | $44.4M | $46.2M | $46.5M | $45.9M | $46.8M | $44.8M | $48.2M | $49.7M | $53.6M | $55.9M | |
| Gross profit | $24.5M | $29M | $30.9M | $35.3M | $38.2M | $42.8M | $46M | $51.3M | $50.8M | $54M | $57.1M | $62.5M | |
| Research & development | $23.7M | $23.1M | $24.1M | $22.5M | $21.1M | $21.3M | $23.9M | $18M | $17M | $17.1M | $19.7M | $18M | |
| Sales & marketing | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $7M | $0 | $0 | $0 | |
| General & administrative | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $56.8M | $0 | $0 | $0 | |
| Other operating expenses | $3.5M | -$31K | -$199K | $44.9M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Operating expenses | $74.6M | $75.9M | $79.8M | $124M | $74.3M | $77.5M | $87.6M | $81.4M | $80.8M | $86.9M | $95.8M | $98.7M | |
| Operating income | -$50.1M | -$47M | -$48.9M | -$88.9M | -$36M | -$34.6M | -$41.6M | -$30.1M | -$29.9M | -$32.9M | -$38.7M | -$36.3M | |
| Interest income | $3.89M | $4.12M | $3.94M | $3.66M | $3.62M | $3.24M | $2.8M | $2.69M | $2.63M | $2.18M | $1.71M | $1.5M | |
| Interest expense | $1K | $0 | $0 | $0 | $29K | $24K | $143K | $0 | $0 | $0 | $0 | $0 | |
| Other non-operating income (gains on investments, FX ...) | -$3.65M | -$4.09M | -$3.74M | -$3.54M | -$1.32M | -$3.17M | -$2.55M | -$50.7M | -$3.05M | $0 | $0 | -$1.54M | |
| Total non-operating income | $3.65M | $4.09M | $3.74M | $3.54M | $1.48M | $3.15M | $2.41M | $50.7M | $3.05M | $2.65M | -$5.32M | $1.54M | |
| Income before tax | -$46.5M | -$42.9M | -$45.1M | -$85.4M | -$34.6M | -$31.5M | -$39.2M | $20.6M | -$26.9M | -$30.3M | -$44M | -$34.7M | |
| Income tax | -$222K | $120K | $345K | $191K | -$96K | $97K | $175K | $191K | $256K | $253K | $43K | -$311K | |
| Net income | -$46.2M | -$43M | -$45.5M | -$85.6M | -$34.7M | -$31.6M | -$39.3M | $20.4M | -$27.1M | -$30.5M | -$44M | -$35.1M | |
| EPS (basic) | -$0.81 | -$0.75 | -$0.79 | -$1.47 | -$0.60 | -$0.53 | -$0.66 | $0.34 | -$0.45 | -$0.50 | -$0.71 | -$0.56 | |
| EPS (diluted) | -$0.81 | -$0.75 | -$0.79 | -$1.47 | -$0.60 | -$0.53 | -$0.66 | $0.33 | -$0.45 | -$0.50 | -$0.71 | -$0.56 | |
| Shares (basic, weighted) | 57.3M | 57.5M | 57.8M | 58.1M | 58M | 59.2M | 59.6M | 60M | 60.4M | 61.1M | 61.7M | 62.4M | |
| Shares (diluted, weighted) | 57.3M | 57.5M | 57.8M | 58.1M | 58M | 59.2M | 59.6M | 61.2M | 60.4M | 61.1M | 61.7M | 62.4M | |
| Depreciation & amortization | $8.5M | $8.17M | $8.3M | $8.3M | $6.66M | $6.38M | $6.4M | $6.07M | $6M | $6.19M | $6.41M | $6.78M | |
| EBITDA | -$38M | -$34.7M | -$36.8M | -$77.1M | -$28.1M | -$25.1M | -$32.6M | $26.6M | -$20.9M | -$26.7M | -$32.2M | -$28M |
| Income statement | Trend | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.27M | $10.8M | $25.4M | $54.4M | $90.1M | $132M | $204M | $245M | $313M | $377M | |
| Cost of revenue | $9.42M | $24M | $32.2M | $47.4M | $61.4M | $80.6M | $119M | $155M | $180M | $186M | |
| Gross profit | -$7.15M | -$13.3M | -$6.76M | $6.96M | $28.7M | $51.7M | $84.2M | $89.7M | $133M | $191M | |
| Research & development | $18.2M | $19.2M | $20.3M | $35.7M | $43M | $69.1M | $120M | $107M | $90.9M | $80.3M | |
| Sales & marketing | $200K | $100K | $900K | $1.3M | $0 | $0 | $0 | $2.9M | $0 | $7M | |
| General & administrative | $18.1M | $26M | $42.6M | $78.8M | $0 | $0 | $0 | $187M | $0 | $240M | |
| Other operating expenses | $73K | -$55K | -$121K | -$265K | $22.5M | -$534K | -$14.2M | $10.3M | $44.9M | $0 | |
| Operating expenses | $36.5M | $45.2M | $63.8M | $116M | $169M | $204M | $319M | $307M | $354M | $327M | |
| Operating income | -$43.7M | -$58.5M | -$70.6M | -$109M | -$140M | -$153M | -$235M | -$217M | -$221M | -$136M | |
| Interest income | $241K | $412K | $999K | $3.03M | $1.5M | $435K | $3.06M | $14.4M | $15.3M | $11.4M | |
| Interest expense | $746K | $905K | $1.31M | $1.29M | $787K | $367K | $80K | $5K | $29K | $0 | |
| Other non-operating income (gains on investments, FX ...) | -$314K | -$357K | -$878K | -$2.77M | -$1.32M | $935K | -$6.58M | -$13.7M | -$12.7M | -$59.3M | |
| Total non-operating income | -$432K | -$548K | -$435K | $1.47M | $530K | -$1.3M | $6.5M | $13.7M | $12.7M | $59.3M | |
| Income before tax | -$44.1M | -$59M | -$71M | -$107M | -$140M | -$154M | -$228M | -$203M | -$208M | -$77M | |
| Income tax | $0 | $280K | $242K | $292K | $382K | -$1.93M | -$10.4M | $1.15M | $560K | $719K | |
| Net income | -$44.1M | -$59.3M | -$71.2M | -$108M | -$140M | -$152M | -$218M | -$205M | -$209M | -$77.7M | |
| EPS (basic) | -$2.35 | -$3.16 | -$2.68 | -$3.92 | -$3.57 | -$3.15 | -$4.04 | -$3.60 | -$3.60 | -$1.30 | |
| EPS (diluted) | -$2.35 | -$3.16 | -$2.68 | -$3.92 | -$3.57 | -$3.15 | -$4.04 | -$3.60 | -$3.60 | -$1.30 | |
| Shares (basic, weighted) | 18.8M | 18.8M | 26.6M | 27.5M | 39.2M | 48.3M | 53.9M | 56.9M | 58M | 59.8M | |
| Shares (diluted, weighted) | 18.8M | 18.8M | 26.6M | 27.5M | 39.2M | 48.3M | 53.9M | 56.9M | 58M | 59.8M | |
| Depreciation & amortization | $4.23M | $5.02M | $5.73M | $6.11M | $6.68M | $9.75M | $16.5M | $29.3M | $31.4M | $24.9M | |
| EBITDA | -$39.1M | -$53.1M | -$64M | -$100M | -$132M | -$144M | -$212M | -$174M | -$177M | -$52.1M |
Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Revenue, operating income and growth
quarterlyMargins
quarterlyCosts as % of revenue
quarterlyThe other statements
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-Q 2025-12-31, 10-K 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-Q 2024-12-31, 10-K 2024-09-30, 10-Q 2024-06-30
Data as of 2026-11-02